With the help of AI, the company’s EPIQ CVx and Affiniti CVx ultrasound systems speed up cardiac ultrasound analysis and reduce the burden on echocardiography labs, Philips said in a news release.
Cardiovascular ultrasounds are a common test to check the heart’s structure and function, and they help in early cardiac disease diagnoses. Amid increases in high acuity cases and patient volumes, cardiologists read hundreds of echocardiography exams every day, according to Roberto Lang, MD, director of the University of Chicago Medicine’s noninvasive cardiac imaging lab.
In the release, Dr. Lang said these new devices can offer results within seconds.
“Trained on anonymized patient data sets from real-life clinical environments, the AI features integrated across Philips cardiovascular ultrasound systems help improve the quality and reproducibility of cardiac imaging and enhance operator and departmental efficiency,” the release said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.